Latest revision as of 19:31, 14 April 2024
Information about message (contribute ) This message has no documentation.
If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Omega-3 fatty acid ) ===Chronic kidney disease=== In people with [[chronic kidney disease]] (CKD) who require hemodialysis, there is a risk that [[vascular blockage]] due to [[Coagulation|clotting]], may prevent dialysis therapy from being possible. Omega-3 fatty acids contribute to the production of [[eicosanoid]] molecules that reduce clotting. However, a Cochrane review in 2018 did not find clear evidence that omega-3 supplementation has any impact on the prevention of vascular blockage in people with CKD. There was also moderate certainty that supplementation did not prevent hospitalisation or death within a 12-month period.
慢性腎臓病
血液透析を必要とする慢性腎臓病 (CKD)の患者では、血液凝固 による血管閉塞 によって透析療法ができなくなる危険性がある。オメガ3脂肪酸は、血液凝固を抑えるエイコサノイド 分子の産生に寄与する。しかし、2018年に行われたコクランレビューでは、オメガ3サプリメントがCKD患者の血管閉塞予防に何らかの影響を与えるという明確な証拠は見つからなかった。また、サプリメントは12ヵ月以内の入院や死亡を予防しないという中程度の確実性もあった。